Parker Lloyd

About Us Margin Acceleration & Value Creation for Healthcare Operators and Investors Slider 2 Slider 2 Slider 2
Unlock Sustainable Financial Performance Across Hospitals, Health Systems, and Healthcare Platforms.

Parker Lloyd partners with hospitals and health systems to unlock sustainable financial performance. We integrate revenue cycle optimization, clinical operations redesign, and supply chain efficiency into a unified margin acceleration strategy.

We also operate at the intersection of capital, operations, and healthcare delivery supporting leadership teams, investors, and partners with execution-focused value creation that improves net collection rate, cost per case, throughput, working capital, and operating margin.

Net Collection Rate

Improve cash realization and reduce leakage

Cost per Case

Create structural efficiency across care delivery

Throughput

Reduce bottlenecks and improve capacity

Working Capital

Release trapped cash through operating discipline

Built for execution

Trusted to support CEOs, CFOs, COOs, boards, operators, and investment partners in turning performance opportunity into measurable, sustained financial improvement.

Operating at the intersection of capital, technology, and healthcare delivery.
Parker Lloyd works alongside investment partners, technology innovators, and healthcare operating stakeholders to drive value creation across complex healthcare environments.

Strategic Partnerships

Private Equity & Investment Partners

Parker Lloyd supports investment firms and portfolio stakeholders with diligence, value creation planning, margin acceleration initiatives, and post-close execution support across healthcare assets.

Technology & Innovation Partners

We align with technology and analytics partners to modernize execution, improve visibility, and accelerate hospital performance through automation, AI, workflow tools, and operating intelligence.

Operating & Industry Partnerships

We collaborate with operators, advisors, and industry platforms that bring sector expertise, relationships, and specialized capabilities to complex healthcare transformation environments.

Hospitals are being squeezed from every angle.

The Challenge

Margins are shrinking. Labor and supply costs remain elevated. Revenue leakage persists. Throughput constraints reduce capacity and delay access. Fragmented transformation efforts often create noise without changing the underlying economics.

Most organizations try to solve these pressures in silos. The real opportunity comes from attacking the full operating model together—revenue, operations, clinical flow, supply chain, governance, and accountability.

What We Improve

An integrated model for margin acceleration and operational value creation.

What We Do

We bring together the financial, operational, clinical, and execution levers that matter most to hospitals, health systems, and healthcare investors.

Medical Education & Accreditation

Expert ACGME/LCME compliance, funding optimization, and program growth strategies to help healthcare organizations build and sustain premier medical education.

Healthcare Operations & Turnaround

We drive operational excellence and financial recovery through expert restructuring, margin acceleration, and measurable performance improvements for healthcare organizations.

Strategic Planning & Execution

Actionable roadmaps and disciplined implementation to accelerate growth, market positioning, and long-term success for healthcare and technology organizations.

Technology Integration & Digital Transformation

We modernize healthcare through EMR implementation, process automation, and digital innovation to enhance efficiency, patient outcomes, and clinical data-driven growth.

Global Market Access & Regulatory Strategy

Accelerating market entry and U.S./international compliance for life sciences and diagnostics through expert regulatory navigation and global growth strategies.

Partnership Development & Stakeholder Alignment

We build high-impact partnerships between health systems, academia, and investors, aligning stakeholders to drive collaboration and unlock cross-functional value.

Experienced operators, advisors, and industry leaders.

Leadership

Parker Lloyd brings together senior executives, operators, and advisors with deep experience across healthcare, private equity, operations, and transformation. This section is designed to showcase leadership profiles and credentials.

Prof. Dr. Yelana Yesha

Senior Advisor in AI

Dr. Maor Elbaz-Starinsky

Senior Strategic Advisor
Joseph Bamberger

Joseph Bamberger

Senior Advisor
Dr. Chalil - Parker Lloyd - Leadership

Dr. Joseph M. Chalil

Managing Partner
Mr. Michael Mark - Parker Lloyd

Mr. Michael Mark

Senior Consulting Partner

Dr. Ravi Kallur

Senior Consultant

Mr. Hamid Ali

Senior Consulting Partner

Adithya Thomas

Legal Associate

Our Partners

Partners we work with

Built for execution, not just advice.

Who We Are

Parker Lloyd is a healthcare-focused transformation and advisory firm specializing in hospital margin acceleration, operational value creation, and strategic execution support. We partner with healthcare leadership teams to unlock measurable financial and operational improvement through integrated execution.

Rather than treating revenue cycle, operations, supply chain, and transformation management as separate workstreams, we align them into a single value creation agenda tied to performance, accountability, and enterprise outcomes.

Our model is particularly effective in environments where leadership needs more than recommendations – where execution, alignment, speed, and measurable results matter.

Where Parker Lloyd creates value.

Where We Create Value

Our work spans hospitals, health systems, operators, and investors that need execution-grade support across performance improvement, value creation, and transformation.

Pre-Acquisition Diligence

Assess hidden EBITDA upside, revenue leakage, cost structure inefficiencies, operational risks, and execution feasibility before capital is deployed.

Post-Acquisition Value Creation

Build and execute 100-day and 12-month margin acceleration plans across revenue cycle, labor productivity, throughput, and supply chain.

Hospital Turnaround & Stabilization

Address declining margins, cash constraints, throughput bottlenecks, and operating model breakdowns through urgent, cross-functional intervention.

System-Wide Transformation

Align enterprise leadership around a unified value creation agenda spanning finance, operations, clinical performance, and cost management.

Growth & Platform Readiness

Prepare organizations for expansion, integration, partnership, or capital events by strengthening performance visibility, controls, and execution discipline.

Interim Strategic Support

Provide executive support, transformation leadership, PMO discipline, and operator-level guidance to CEOs, CFOs, COOs, and boards during periods of change.

A private equity-style value creation approach built for healthcare.

Our Approach

We combine diagnostic rigor, operating discipline, cross-functional alignment, and hands-on implementation to move from insight to measurable results.

Diagnose

We rapidly assess revenue, operational, and supply chain performance to identify hidden margin opportunities, quantify value at stake, and establish a credible baseline for action.

Design

We build an integrated value creation roadmap with priority workstreams, accountable owners, financial impact estimates, practical milestones, and measurable KPIs.

Execute

We work shoulder-to-shoulder with leadership teams to implement change, remove bottlenecks, accelerate adoption, and deliver measurable results—not just presentations.

Sustain

We embed governance, performance management, cadence reviews, and operating discipline so improvements hold and continue after implementation.

Focused. Specialized. Accountable.

Why Parker Lloyd

We are not a generic consulting firm. We are built to help healthcare organizations and investors convert operational complexity into measurable financial improvement.

Our model emphasizes embedded execution, leadership alignment, value creation discipline, operational rigor, and sustained performance management.

We bring a practical blend of strategy, execution, operator mindset, and healthcare-specific transformation capability.

Selected sectors and stakeholders

Who We Work With

Community Hospitals

Regional Health Systems

Academic and Teaching Hospitals

Multi-Site Provider Networks

Private Equity-Backed Healthcare Platforms

Ambulatory and Specialty Care Networks

Boards, CEOs, CFOs, and COOs

Private equity firms and portfolio leaders

Transformation offices and PMO teams

Operating partners and strategic advisors

Unlock hidden margin and value across your organization.

Executive Discussion

If your organization is facing margin pressure, rising operational costs, throughput bottlenecks, working capital constraints, or execution gaps, Parker Lloyd can help identify and activate the levers that move performance.

Expert Insights To Improve Your Business Operations

Our Latest Articles
Investing is one of the most effective ways to build wealth, achieve financial security, and create long-term financial freedom.

Secure Your Strategic Advantage!

Ready to work with us?

If your organization is seeking to unlock margin, accelerate operational improvement, or drive sustainable value creation, Parker Lloyd is ready to help. Connect with our team for a confidential discussion about your challenges and opportunities. We partner with healthcare leaders, operators, and investors to deliver measurable results – beyond recommendations, through hands-on execution.

Let’s explore how Parker Lloyd can support your goals and help you achieve lasting financial and operational performance.

    Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
    • Image
    • SKU
    • Rating
    • Price
    • Stock
    • Availability
    • Add to cart
    • Description
    • Content
    • Weight
    • Dimensions
    • Additional information
    Click outside to hide the comparison bar
    Compare

    Dr. Maor Elbaz-Starinsky is Senior Strategic Advisor at Parker Lloyd LLC, where he provides strategic counsel on international diplomacy, government relations, market access, and cross-border partnerships, with a particular focus on Israel and the United States. Drawing on nearly two decades of diplomatic leadership across four continents and an academic foundation in the life sciences, he advises clients navigating complex regulatory environments, developing strategic alliances, and expanding internationally, particularly in life sciences, healthcare technology, diagnostics, and infrastructure. His work sits at the intersection of diplomacy, innovation, venture capital, and healthcare, helping organizations connect governments, academia, industry, and private capital to accelerate international growth. As an Israeli and Portuguese citizen with an extensive international diplomatic network, Maor brings a uniquely global perspective and cross-cultural insight to organizations pursuing international expansion and strategic partnerships.

    A career diplomat with the Ministry of Foreign Affairs of the State of Israel since 2006, Maor most recently served as Consul General of Israel in Miami (2021-2025), representing Israel across Florida, Kansas, Missouri, and Puerto Rico. In that role, he strengthened bilateral relations across government, business, academia, innovation, tourism, media, and culture while fostering partnerships between public and private sector leaders. He led initiatives promoting economic cooperation, technology partnerships, trade missions, and investment, while advancing interfaith dialogue and efforts to combat antisemitism and racism.

    Previously, Maor headed the Training Department at Israel’s Ministry of Foreign Affairs, where he oversaw professional development, leadership training, and recruitment for approximately 1,200 employees. He received the Ministry’s Award of Excellence for redesigning the Diplomatic Cadet training program. Earlier in his career, he served in the Strategic Affairs Division, representing Israel at international arms control forums, and as Policy Adviser to the Israeli Delegation to the European Union and NATO in Brussels (2011-2014), managing regional strategic and security affairs. His first overseas posting was as Deputy Ambassador at the Embassy of Israel in Nairobi (2008-2011), with concurrent accreditation to Uganda, Tanzania, Malawi, Zambia, and the Seychelles, where he advanced regional cooperation in security, agriculture, trade, innovation, and development across East Africa.

    Maor holds an MA with distinction in Conflict Management and Resolution from the Hebrew University of Jerusalem. He also pursued graduate studies in Immunology at Tel Aviv University’s Graduate School of Medicine and earned a BA in Biology from Tel Aviv University, conducting research in marine and molecular biology. He served as a commander in the Israel Defense Forces Paratroopers.

    At Parker Lloyd, Maor combines extensive diplomatic experience, a global network spanning government, industry, academia, investors, healthcare innovators, and policymakers with deep expertise in international strategy to help clients identify opportunities, navigate geopolitical and regulatory complexities, forge strategic partnerships, and accelerate growth across global markets.

    Joseph Bamberger is the Founder and CEO of Geneva Private Equity, a MedTech-focused firm investing in and commercializing early-stage diagnostics, imaging, and screening technologies. A distinguished financial strategist and born leader, he brings over a decade of experience in fixed income and debt restructuring, having personally overseen more than $10 billion in transactions. He previously founded Jade Capital, a boutique advisory firm serving ultra-high-net-worth clients across real estate and structured credit.

    As Senior Advisor to Parker Lloyd LLC, Joseph partners with the firm to support healthcare operators, investors, and portfolio companies with capital structuring, commercialization strategies, and value creation initiatives. His expertise strengthens Parker Lloyd’s ability to accelerate market entry, operational scaling, and sustainable growth for innovative MedTech and diagnostics platforms. He combines deep financial engineering with sharp strategic instincts to commercialize clinical-stage technologies and build resilient businesses positioned for long-term success and meaningful patient impact.

    Joseph’s blend of hands-on investment leadership, transaction expertise, and a focus on commercialization makes him a valuable strategic partner for Parker Lloyd’s work at the intersection of capital, technology, and healthcare delivery.

    Prof. Dr. Yelana Yesha serves as Senior Advisor in AI at Parker Lloyd, where she provides strategic counsel on artificial intelligence, machine learning, data science, digital twins, and their transformative applications in healthcare innovation, precision medicine, cybersecurity, and emerging technologies. Her guidance supports the firm’s work with healthcare technology companies, diagnostics innovators, and life sciences investments seeking to translate advanced computational methods into scalable, trustworthy clinical and operational solutions.

    She is the John S. and James L. Knight Foundation Endowed Chair of Data Science and Artificial Intelligence at the University of Miami. At the Frost Institute for Data Science and Computing, she serves as Professor of Computer Science, Professor of Radiology, Director of the AI and Machine Learning Program, and Innovation Officer for the Frost Institute. Her joint appointment in Radiology reflects a sustained commitment to collaborative, clinically grounded AI research.
    With more than three decades of leadership spanning academia, government, and industry, Prof. Dr. Yesha previously served as Distinguished University Professor at the University of Maryland, Baltimore County (UMBC), where she directed the National Science Foundation Centers for Accelerated Real Time Analytics (CARTA) and Hybrid Multicore Productivity Research (CHMPR). Earlier, as Director of the Center of Excellence in Space Data and Information Sciences (CESDIS) at NASA Goddard Space Flight Center, she grew the institute’s budget sixfold, oversaw development of the Beowulf parallel computing architecture, contributed to key Linux components, and supported technologies used in the Hubble Space Telescope repair. While directing the Center for Applied Information Technology at NIST, she represented the United States at cabinet-level G7 meetings and led architecture for federal electronic commerce procurement systems now processing hundreds of billions of dollars annually.

    Prof. Dr. Yesha has served as Principal Investigator or Co-Principal Investigator on numerous major research awards from the National Science Foundation, NASA, Department of Homeland Security, Department of Veterans Affairs, FDA, and industry partners. Her recent work focuses on clinical AI at scale—including machine learning models for venous thromboembolism (VTE) risk prediction that outperform traditional scoring tools, AI systems for radiology interpretation and dermatology, digital twins for neurological conditions such as Parkinson’s disease and dementia, and frameworks for continuous monitoring and evaluation of deployed AI models developed in collaboration with the FDA. She has also advanced blockchain-based architectures for secure clinical data sharing, IoT, and space resource management, as well as research on room-temperature quantum computing architectures and nutritional intelligence platforms.

    Prof. Dr. Yesha’s unique combination of deep technical expertise, proven ability to build and deploy real-world systems, and extensive experience bridging AI research with clinical, regulatory, and infrastructure needs makes her an exceptional advisor to Parker Lloyd and its clients pursuing AI-enabled healthcare transformation.

    Adithya Thomas serves as Legal Associate – India Division at Parker Lloyd, where he supports cross-border corporate transactions, commercial structuring and regulatory advisory across global markets. His work focuses on contract drafting, risk assessment and assisting clients navigating complex multi-jurisdictional legal frameworks.

    An internationally trained lawyer, Adithya has gained experience across Europe, Asia and Australia, having worked with law firms in Portugal, Spain, Germany, India and Australia. His background spans corporate and commercial law, contract negotiation and regulatory compliance, with exposure to high-value and cross-border matters involving diverse stakeholders.

    Prior to joining Parker Lloyd, Adithya worked with JMPM Advogados in Portugal, where he was involved in international dispute work and commercial contract drafting. He has also worked with firms including BluePort Legal (Germany), Himnus Football Lawyers (Spain), Krida Sports Legal (India) and LY Legal (Australia), where he developed a strong foundation in corporate structuring, commercial agreements and legal risk management in international business environments.

    Adithya holds a Bachelor of Business Administration and Bachelor of Laws (BBA LL.B) from Christ University, India, and an LL.M. in International Sports Law from ISDE University, Madrid. He also completed an academic programme at the University of Cambridge focused on the legal and governance frameworks of global sport.

    At Parker Lloyd, Adithya contributes to delivering commercially focused legal solutions, combining international exposure with a practical understanding of cross-border business operations.

    Mr.  Hamid Ali serves as a Senior Consulting Partner at Parker Lloyd, where he advises executive leadership, investors, and operating teams on strategy development, growth acceleration, and large-scale transformation initiatives across diverse industries.

    With more than 25 years of global leadership experience, Mr. Ali has collaborated closely with CEOs and senior stakeholders to deliver measurable results in healthcare, financial services, manufacturing, and technology sectors. He spent 17 years at Genpact, where he supported GE Healthcare in executing complex global operations and transformation programs, driving efficiency, process optimization, and strategic alignment on an international scale. In addition, he accumulated over a decade of specialized experience in banking and financial services consulting, advising on operational excellence, risk management, and market expansion strategies.

    At Parker Lloyd, Mr. Ali concentrates on identifying and cultivating strategic partnerships, supporting revenue and market growth initiatives, and assisting organizations in converting strategic opportunities into effective execution. Renowned for his collaborative leadership style, he excels at introducing structure, clarity, and sustained momentum to dynamic and evolving business environments, enabling clients to achieve their objectives with precision and agility.

    Mr. Ali’s expertise encompasses strategic planning, operational transformation, partnership development, cross-functional team leadership, and the translation of high-level vision into actionable outcomes. His proven ability to navigate complex, multi-stakeholder settings positions him as a trusted advisor for organizations seeking sustainable growth and competitive advantage.

    Dr. Ravi Kallur, PhD, MPA, serves as a Senior Consultant at Parker Lloyd, where he delivers specialized expertise in graduate medical education (GME), undergraduate medical education (UME), institutional accreditation, and strategic development for healthcare organizations and academic partners. In addition, Dr. Kallur currently acts as a Senior Advisor to Prime Healthcare, providing high-level counsel on medical education initiatives, program expansion, and regulatory compliance within the system's network of hospitals and facilities.

    With more than 20 years of executive leadership in medical education, Dr. Kallur has successfully developed and secured accreditation for over 35 new residency and fellowship programs under the Accreditation Council for Graduate Medical Education (ACGME). His notable achievements include establishing sponsoring institutions with initial accreditation, obtaining ACGME initial accreditation for multiple residency programs, and managing the seamless transition of large GME portfolios encompassing hundreds of residents and fellows across hospital systems. He has consistently optimized operations to enhance funding opportunities, including CMS reimbursement and state-designated statutory teaching hospital status, which have collectively generated millions in additional resources.

    Since 2022, in his consulting capacity, Dr. Kallur has established two sponsoring institutions with initial accreditation, secured initial ACGME accreditation for five residency programs, and supported the transition of 10 GME programs involving 200 residents and fellows. Previously, as Division Vice President and Designated Institutional Official (DIO) at HCA, he managed budgets exceeding $50 million, achieved statutory teaching hospital designations that yielded substantial state funding (including $9 million for two hospitals), and oversaw the accreditation of numerous new programs. He also served as a primary liaison with medical schools such as Nova Southeastern University and Florida International University, while hiring key academic leadership and managing extensive teams.

    In his earlier role as Senior Vice President and DIO at Baylor Scott & White Health, Dr. Kallur reduced unfunded resident positions through strategic VA partnerships, secured multimillion-dollar grants from the Texas Higher Education Coordinating Board, and led departmental integrations following institutional mergers. At Children's Mercy Hospital, he contributed to the launch of 12 new pediatric fellowships and served as a key liaison for international faculty recruitment and consortium finance.

    Dr. Kallur holds a PhD in Higher Education Administration and a Master of Public Administration (with a focus on Health Administration) from the University of Missouri-Kansas City. He maintains active memberships in the Association of American Medical Colleges (AAMC) and the Accreditation Council for Graduate Medical Education (ACGME). His academic appointments include Affiliate Associate Professor and Affiliate Associate Dean at Nova Southeastern University's Dr. Kiran C. Patel College of Allopathic Medicine and Florida International University's Herbert Wertheim College of Medicine, among others.

    Dr. Kallur's proficiency spans strategic planning, budget management, faculty and staff recruitment, accreditation compliance (ACGME and LCME), process optimization, and the cultivation of effective partnerships between health systems and educational institutions. He remains dedicated to advancing superior medical education standards that improve patient outcomes, institutional efficiency, and long-term organizational success.

    Mr. Michael Mark serves as a Senior Consulting Partner at Parker Lloyd, where he provides strategic leadership and advisory services to healthcare organizations, focusing on start-up ventures, turnaround initiatives, managed care operations, and technology-driven solutions in the healthcare sector.

    With more than 40 years of senior executive experience in the healthcare industry, Mr. Mark has established himself as a proven leader in profit-and-loss management, organizational restructuring, and revenue growth for health plans, provider organizations, and technology firms. He has served as President and CEO of several managed care entities, including Blue Care Network, Health Plus, Methodist Memphis PHO, and DMC Care, where he was responsible for annual revenues totaling approximately $3.4 billion and the management of more than 3,300 employees.

    In his technology leadership roles, Mr. Mark held senior positions at Science Applications International Corporation (SAIC), Computer Sciences Corporation (CSC), and Superior Consultant. At CSC, he directed the comprehensive restructuring of sales, information technology operations, and service delivery organizations, incorporating offerings such as data center operations, claims transaction adjudication, business solution centers, back-room operations, and process improvement. This included managing Business Process Outsourcing for New York State Medicaid. During his tenure at SAIC, he led the development of a broad portfolio of healthcare services and supported Kaiser Permanente’s implementation of the Epic electronic medical record system. He also collaborated with high-level federal officials, including the retired Assistant Secretary of Defense for Health Affairs and the retired Surgeons General of the Army, Navy, and Air Force, to advance solutions for the Military Health System (MHS), Centers for Medicare and Medicaid Services (CMS), Tricare, and the Centers for Disease Control and Prevention.

    Mr. Mark excels in guiding small to medium-sized healthcare businesses toward achieving market positioning, operational efficiency, and revenue objectives. His expertise encompasses strategic planning, executive leadership, process optimization, and the integration of technology with healthcare delivery to drive sustainable performance and organizational success. At Parker Lloyd, he applies this extensive background to assist clients in navigating complex healthcare challenges, enhancing competitive positioning, and realizing long-term strategic goals.

    Dr. Joseph M. Chalil serves as Managing Partner of Parker Lloyd, where he leads the firm’s U.S. operations and provides high-level strategic advisory and investment guidance in life sciences, healthcare technology, diagnostics, and global healthcare infrastructure. In addition, Dr. Chalil serves as Chief Medical Advisor at Geneva Private Equity, where he offers expert medical and scientific counsel on investment strategies and portfolio companies in the healthcare and life sciences sectors.

    A strategic clinical and business leader with over 26 years of global experience in the pharmaceutical, biotechnology, and healthcare sectors, Dr. Chalil has held senior leadership positions at major pharmaceutical companies, including Abbott, Hoffmann-La Roche, Boehringer Ingelheim, and DBV Technologies.

    Since joining Parker Lloyd in 2025, Dr. Chalil has advised foreign healthcare and diagnostics companies on U.S. market entry, including 510(k) and De Novo submissions, CLIA waiver strategies, clinical trial design, ISO 13485/MDSAP compliance, and commercial launches. He also guides U.S. corporations on expansion into APAC, MENA, and EU markets through joint ventures, licensing, and distribution agreements, unlocking significant pipeline value.

    An accomplished inventor, Dr. Chalil holds seven U.S. and international patents in CMOS-MEMS hybrid integrated technologies. He is the bestselling author of two influential books on global healthcare transformation: India Beyond the Pandemic: A Sustainable Path Towards Global Quality Healthcare (2024) and Beyond the COVID-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare (2020). Recognized as a World-Class Media Influencer, he regularly authors op-eds and white papers on healthcare policy, innovation, and market-driven regulations for global access.

    Dr. Chalil serves as Advisor to the Ministry of Health in the Government of India. He is a U.S. Navy Medical Corps veteran and Fellow of the American College of Healthcare Executives (FACHE). He holds academic appointments at Nova Southeastern University, including Adjunct Professor and Chair of the Complex Health Systems Advisory Board at the H. Wayne Huizenga College of Business & Entrepreneurship, and Advisory Board Member at the Ron and Kathy Assaf College of Nursing. He is also pursuing an LLM in Medical Law and Ethics at the University of Edinburgh Law School.

    Dr. Chalil combines deep clinical expertise, pharmaceutical industry leadership, regulatory acumen, and strategic vision to help organizations navigate complex global healthcare environments, forge transformative partnerships, and deliver innovative, patient-centered solutions worldwide.

    Shopping cart close